110 related articles for article (PubMed ID: 40965)
1. The effect of antipsychotic drugs on body weight: a retrospective review.
Doss FW
J Clin Psychiatry; 1979 Dec; 40(12):528-30. PubMed ID: 40965
[TBL] [Abstract][Full Text] [Related]
2. Loxapine: a review of its pharmacological properties and therapeutic efficacy as an antipsychotic agent.
Heel RC; Brogden RN; Speight TM; Avery GS
Drugs; 1978 Mar; 15(3):198-217. PubMed ID: 25167
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of five antischizophrenic agents against Toxoplasma gondii in human cell cultures.
Goodwin DG; Strobl JS; Lindsay DS
J Parasitol; 2011 Feb; 97(1):148-51. PubMed ID: 21348624
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic and pharmacokinetic considerations in choosing an antipsychotic.
Ereshefsky L
J Clin Psychiatry; 1999; 60 Suppl 10():20-30. PubMed ID: 10340684
[TBL] [Abstract][Full Text] [Related]
5. Does loxapine have "atypical" properties? Clinical evidence.
Glazer WM
J Clin Psychiatry; 1999; 60 Suppl 10():42-6. PubMed ID: 10340686
[TBL] [Abstract][Full Text] [Related]
6. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
[TBL] [Abstract][Full Text] [Related]
7. Weight gain associated with atypical and typical antipsychotics during treatment of adolescent schizophrenic psychoses: A retrospective study.
Hrdlicka M; Zedkova I; Blatny M; Urbanek T
Neuro Endocrinol Lett; 2009; 30(2):256-61. PubMed ID: 19675512
[TBL] [Abstract][Full Text] [Related]
8. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.
Baptista T; Kin NM; Beaulieu S; de Baptista EA
Pharmacopsychiatry; 2002 Nov; 35(6):205-19. PubMed ID: 12518268
[TBL] [Abstract][Full Text] [Related]
9. Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors.
Herrick-Davis K; Grinde E; Teitler M
J Pharmacol Exp Ther; 2000 Oct; 295(1):226-32. PubMed ID: 10991983
[TBL] [Abstract][Full Text] [Related]
10. Correlations between weight changes and lipid profile changes in schizophrenic patients after antipsychotics therapy.
Huang TL; Lu CY
Chang Gung Med J; 2007; 30(1):26-32. PubMed ID: 17477026
[TBL] [Abstract][Full Text] [Related]
11. Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate.
Cookson JC; Kennedy NM; Gribbon D
Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():41-51. PubMed ID: 3549879
[TBL] [Abstract][Full Text] [Related]
12. Use and safety of antipsychotic drugs during pregnancy.
Einarson A; Boskovic R
J Psychiatr Pract; 2009 May; 15(3):183-92. PubMed ID: 19461391
[TBL] [Abstract][Full Text] [Related]
13. Dopamine antagonism by thioridazine in schizophrenia.
Meltzer HY; Sachar EJ; Frantz AG
Biol Psychiatry; 1975 Feb; 10(1):53-7. PubMed ID: 1120175
[TBL] [Abstract][Full Text] [Related]
14. Brain homovanillic acid: regional changes following chronic antipsychotic drug administration.
Bowers MB; Rozitis A
Adv Biochem Psychopharmacol; 1977; 16():639-44. PubMed ID: 18907
[No Abstract] [Full Text] [Related]
15. Binding of psychotropic drugs to isolated alpha-acid glycoprotein.
Kornguth ML; Hutchins LG; Eichelman BS
Biochem Pharmacol; 1981 Sep; 30(17):2435-41. PubMed ID: 21043242
[TBL] [Abstract][Full Text] [Related]
16. Drug interactions on spontaneous locomotor activity in rats. Neuroleptics and amphetamine-induced hyperactivity.
Schaefer GJ; Michael RP
Neuropharmacology; 1984 Aug; 23(8):909-14. PubMed ID: 6148710
[TBL] [Abstract][Full Text] [Related]
17. A comparison of parenteral loxapine and haloperidol in hostile and aggressive acutely schizophrenic patients.
Tuason VB
J Clin Psychiatry; 1986 Mar; 47(3):126-9. PubMed ID: 3512535
[TBL] [Abstract][Full Text] [Related]
18. No association of antipsychotic agent-induced weight gain with a DA receptor gene polymorphism and therapeutic response.
Zhang ZJ; Yao ZJ; Zhang XB; Chen JF; Sun J; Yao H; Hou G; Zhang XB
Acta Pharmacol Sin; 2003 Mar; 24(3):235-40. PubMed ID: 12617772
[TBL] [Abstract][Full Text] [Related]
19. Atypical antipsychotics: mechanism of action.
Seeman P
Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
[TBL] [Abstract][Full Text] [Related]
20. Weight change with atypical antipsychotics in the treatment of schizophrenia.
Haddad P
J Psychopharmacol; 2005 Nov; 19(6 Suppl):16-27. PubMed ID: 16280334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
